Skip to main content
OpenTrials

Clinical trial condition

Ovarian Diseases

Explore clinical trials studying Ovarian Diseases. Study availability and eligibility vary by location and protocol.

3,397 public trials 657 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Diseases trial results

Completed

Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer

NCT00097409

Conditions
Adnexal Diseases, Disease Attributes, Endocrine Gland Neoplasms, +17 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site New Orleans, Louisiana, United States
  • GSK Investigational Site St Louis, Missouri, United States
  • GSK Investigational Site Mayfield Heights, Ohio, United States
View Trial Details
Completed

Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer

NCT00049465

Conditions
Adnexal Diseases, Behavior, Behavioral Symptoms, +105 more
Locations
  • Stanford University Medical Center Stanford, California, United States
  • AMC Cancer Research Center Denver, Colorado, United States
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • Shands Hospital and Clinics, University of Florida Gainesville, Florida, United States
View Trial Details
Completed

Docetaxel and Carboplatin in Treating Patients With Relapsed Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cavity Cancer

NCT00217568

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +18 more
Locations
  • Pacific Gynecology Specialists Seattle, Washington, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
  • University of Washington School of Medicine Seattle, Washington, United States
View Trial Details
Completed

Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation

NCT00045292

Conditions
Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +108 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Stanford Cancer Center at Stanford University Medical Center Stanford, California, United States
  • UNMC Eppley Cancer Center at the University of Nebraska Medical Center Omaha, Nebraska, United States
  • Baylor University Medical Center Dallas, Texas, United States
View Trial Details
Completed

Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer

NCT00217529

Conditions
Adnexal Diseases, Brenner Tumor, Carcinoma, +26 more
Locations
  • Pacific Gynecology Specialists Seattle, Washington, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
  • University of Washington School of Medicine Seattle, Washington, United States
View Trial Details

Related conditions